KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwill & IntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Clover Health Investments (CLOV) Payables (2020 - 2025)

Clover Health Investments (CLOV) has disclosed Payables for 6 consecutive years, with $32.9 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Payables rose 27.93% year-over-year to $32.9 million, compared with a TTM value of $32.9 million through Sep 2025, up 27.93%, and an annual FY2024 reading of $34.6 million, up 135.13% over the prior year.
  • Payables was $32.9 million for Q3 2025 at Clover Health Investments, down from $34.0 million in the prior quarter.
  • Across five years, Payables topped out at $39.9 million in Q2 2023 and bottomed at $11.2 million in Q2 2021.
  • Average Payables over 5 years is $24.9 million, with a median of $26.6 million recorded in 2022.
  • The sharpest move saw Payables soared 13148.33% in 2021, then crashed 62.67% in 2024.
  • Year by year, Payables stood at $28.1 million in 2021, then increased by 15.34% to $32.4 million in 2022, then crashed by 54.69% to $14.7 million in 2023, then soared by 135.13% to $34.6 million in 2024, then fell by 4.7% to $32.9 million in 2025.
  • Business Quant data shows Payables for CLOV at $32.9 million in Q3 2025, $34.0 million in Q2 2025, and $30.6 million in Q1 2025.